Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dainippon Sumitomo Pharma raises mid-year consolidated net profit outlook for FY 2015


Wednesday, 30 Jul 2014 02:00am EDT 

Dainippon Sumitomo Pharma Co Ltd:Mid-year consolidated outlook for revenue of 178,000 mln yen, for fiscal year ending March 2015.Mid-year operating profit outlook of 12,000 mln yen.Mid-year ordinary profit outlook of 11,500 mln yen.Mid-year net profit outlook of 11,000 mln yen raised from 6,300 mln yen.Mid-year earnings per share outlook of 27.69 yen raised from 15.86 yen.Net profit outlook raised due to extraordinary profit caused by reorganization of idle assets. 

Company Quote

1256.0
1.0 +0.08%
21 Nov 2014